References
- International Diabetes Foundation [homepage on the Internet]IDF Diabetes Atlas7th Edition2015 Available from: http://www.diabetesatlas.orgAccessed February 1, 2016
- Japan Diabetes Society [webpage on the Internet]Treatment Guide for Diabetes20122013 Available from: http://www.jds.or.jp/modules/en/index.php?content_id=1Accessed February 1, 2016
- TrujilloJMNufferWEllisSLGLP-1 receptor agonists: a review of head-to-head clinical studiesTher Adv Endocrinol Metab201561192825678953
- Pharmaceuticals and Medical Devices Agency [webpage on the Internet]New Drugs Available from: http://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0002.htmlAccessed January 26, 2016
- OkumuraKInoueHYasakaMComparing patient and physician risk tolerance for bleeding events associated with anticoagulants in atrial fibrillation-evidence from the United States and JapanValue Health Reg Issues201566572
- KawaguchiTAzumaKYamaguchiTPreferences for pharmacist counselling in patients with breast cancer: a discrete choice experimentBiol Pharm Bull201437111795180225212541
- KimotoYMurataTLloydAJNafeesBDiscrete choice experiment to estimate preference and willingness to pay on intermittent urinary catheters in patients with voiding dysfunction from neurogenic bladderTher Res2015367683697
- GelhornHLStringerSMBrooksAPreferences for medication attributes among patients with type 2 diabetes mellitus in the UKDiabetes Obes Metab201315980280923464623
- HauberABTunceliKYangJCA survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitusDiabetes Ther201561758425586555
- MühlbacherABethgeSWhat matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferencesEur J Health Econ Epub20151218
- HauberABNguyenHPosnerJKalsekarIRugglesJA discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetesCurr Med Res Opin201632225126226549576
- GelhornHLPoonJLDaviesEWPaczkowskiRCurtisSEBoyeKSEvaluating preferences for profiles of GLP-1 receptor agonists among injection-naive type 2 diabetes patients in the UKPatient Prefer Adherence201591611162226635470
- MiyagawaJOdawaraMTakamuraTIwamotoNTakitaYImaokaTOnce-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III studyDiabetes Obes Metab2015171097498326179187
- PolsterMZanuttoEMcDonaldSConnerCHammerMA comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetesJ Med Econ201013465566121034377
- MarshallDBridgesJFHauberBConjoint analysis applications in health – how are studies being designed and reported?: an update on current practice in the published literature between 2005 and 2008Patient20103424925622273432
- KuhfeldWF webpage on the InternetMarketing Research Methods in SAS: Experimental Design, Choice, Conjoint, and Graphical TechniquesSAS 9.2 EditionMR-20102010 Available from: http://support.sas.com/techsup/technote/mr2010.pdfAccessed April 13, 2015
- OrmeBGetting Started with Conjoint Analysis: Strategies for Product Design and Pricing ResearchMadison, WIResearch Publishers, LLC2005
- Lilly Diabetes [webpage on the Internet]Instructions for Use: Trulicity® 0.75 mg Single-Use Pre-Filled Pen Ateos® (Dulaglutide) Available from: https://www.diabetes.co.jp/usage/trulicity.aspxAccessed February 1, 2016
- Novo Nordisk [webpage on the Internet]Instructions for Use: Victoza® 6 mg/mL Solution for Injection in Pre-Filled Pen (Liraglutide) Available from: http://www.novonordiskpro.jp/content/dam/nnpro/japan/ja/products/victoza/documents/victoza_use_correctly.pdfAccessed February 1, 2016
- GelhornHLStringerSMReindersSSchreebKHGerman patients’ preferences for attributes of type 2 diabetes medicationsPaper presented at: The ISPOR 17th Annual European CongressNovember 8–122014Amsterdam, the Netherlands
- XieJSuzukiSCosXHassounAMatsubaIPolinskiJMCross-national variation in physicians’ characteristics and their goals for patients taking insulin: a global perspective from the MOSAIc studyPaper presented at: American Diabetes Association 74th Annual Scientific SessionJune 13–172014San Francisco, CA
- DunganKMPovedanoSTForstTEfficacy and safety of once weekly dulaglutide versus once daily liraglutide in type 2 diabetes (AWARD-6)Paper presented at: American Diabetes Association’s 74th Scientific SessionsJune 13–172014San Francisco, CA
- NamSCheslaCStottsNAKroonLJansonSLBarriers to diabetes management: patient and provider factorsDiabetes Res Clin Pract20119311921382643